According to filings with the U.S. Securities and Exchange Commission, Develo is raising up to $13,999,989.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Develo
Develo was founded on our heartfelt conviction that while children are 1/3 of the US population, they are 100% of our future. Despite this reality, healthcare technology companies have largely overlooked the unique needs of pediatricians. Develo is changing that paradigm by offering the first end-to-end software solution tailored exclusively for independent pediatric practices. ?We believe that a software revolution is overdue for pediatricians. Instead of settling for traditional EMRs, pediatricians should expect and demand delightful, seamlessly connected experiences. Workflows should not be disjointed across piecemeal modules, and features like AI scribe and AI charge capture should be seamlessly built into the day-to-day visit flow. Practices should also seek to deliver the family-first experience that patients and parents increasingly crave. We are also firm believers that modern pediatric software must be underpinned by forward-looking foundations. Develo’s AI native, FHIR-conformant, and family-centered data architecture perfectly aligns with this imperative. With fundamentals in place for pediatric innovation at 10x pace of legacy vendors, Develo is poised to swiftly introduce the latest artificial intelligence and automation technologies to deliver outsized clinical, financial, and operational value to independent pediatric practices.

To learn more about Develo, visit https://develo.com/
Develo Linkedin Page: https://www.linkedin.com/company/getdevelo/

Contact:
Aaron Tsz-KitSin, Chief Executive Officer
415-690-3952
https://www.linkedin.com/in/aaronsin/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.